BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lu MY, Wei YJ, Wang CW, Liang PC, Yeh ML, Tsai YS, Tsai PC, Ko YM, Lin CC, Chen KY, Lin YH, Jang TY, Hsieh MY, Lin ZY, Huang CF, Huang JF, Dai CY, Chuang WL, Yu ML. Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes. World J Gastroenterol 2025; 31(10): 103716 [PMID: 40093674 DOI: 10.3748/wjg.v31.i10.103716]
URL: https://www.wjgnet.com/1007-9327/full/v31/i10/103716.htm
Number Citing Articles
1
Yu-Ning Gao, Mei-Ling Chen, Wen-Mao Li, Qing Liu, Yan Jiao. Advancing the diagnosis and treatment of metabolic-associated steatotic liver disease: The transformative role of artificial intelligenceArtificial Intelligence in Gastroenterology 2025; 6(1): 107105 doi: 10.35712/aig.v6.i1.107105